IVEVFPNKHealthcare
Inventiva S.A.
+20.0% · 90d
$5.50
+0.17 (+3.19%)
News
(2)April 2026
5 days ago6-K
Inventiva Retools Leadership Ahead of Phase 3 Drug Trial Data
IVEVFInventiva S.A.
# 🧾 What This Document Is This is a **6-K filing**, which is a report foreign companies (like French-based Inventiva) submit to the SEC to announce major news. This specific filing contains a press release. Think of it as an official, legally required announcement to investors about a significant c
Read summaryView on SEC EDGAR
March 2026
0 months ago6-K
Inventiva S.A. — 6-K Filing
IVEVFInventiva S.A.
# 🔍 What This Document Is This is a **Form 6-K** filing from Inventiva, a French-American biotech company. It's essentially their **2025 annual report** wrapped in a press release, giving investors a full business and financial update. It explains how they spent their money, what progress they mad
Read summaryView on SEC EDGAR